However, we found that these agents inhibited activation of NF-κB and STAT3, which may be linked to their anticancer mechanism, since NF-κB and STAT3 are found to be activated in most cancers (Chaturvedi et al., 2011). This evidence concerns the gene STAT3 and cancer.